Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2018

  • ID: 4580367
  • Report
  • 138 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Altura Medical Inc
  • Cook Medical Inc
  • Endologix Inc
  • Kawasumi Laboratories Inc
  • MicroPort Scientific Corp
  • Terumo Aortic
  • MORE
Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2018

Summary

The Medical Devices sector report, “Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2018" provides an overview of Abdominal Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Abdominal Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by The team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Abdominal Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Abdominal Aortic Stent Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Abdominal Aortic Stent Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Altura Medical Inc
  • Cook Medical Inc
  • Endologix Inc
  • Kawasumi Laboratories Inc
  • MicroPort Scientific Corp
  • Terumo Aortic
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Abdominal Aortic Stent Grafts Overview

3 Products under Development
3.1 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
3.2 Abdominal Aortic Stent Grafts - Pipeline Products by Territory
3.3 Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path
3.4 Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
3.5 Abdominal Aortic Stent Grafts - Ongoing Clinical Trials

4 Abdominal Aortic Stent Grafts - Pipeline Products under Development by Companies
4.1 Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
4.2 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development

5 Abdominal Aortic Stent Grafts Companies and Product Overview
5.1 Altura Medical Inc Company Overview
5.1.1 Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 BiFlow Medical Ltd Company Overview
5.2.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Cook Medical Inc Company Overview
5.3.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cordis Corp Company Overview
5.4.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.5.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.6 Endologix Inc Company Overview
5.6.1 Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Endoluminal Sciences Pty Ltd. Company Overview
5.7.1 Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Hadassah Medical Center Company Overview
5.8.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.9 Kawasumi Laboratories Inc Company Overview
5.9.1 Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.10.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.11 Lombard Medical Technologies Inc. Company Overview
5.11.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.12 Lombard Medical Technologies Ltd Company Overview
5.12.1 Lombard Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 Medtronic plc Company Overview
5.13.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.14 MicroPort Scientific Corp Company Overview
5.14.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.15 St. Jude Medical LLC Company Overview
5.15.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.16 Terumo Aortic Company Overview
5.16.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview
5.17 TriVascular Inc Company Overview
5.17.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 University of Colorado Denver Company Overview
5.18.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of Limerick Company Overview
5.19.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview
5.20 Venus MedTech Company Overview
5.20.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview
5.21 W. L. Gore & Associates Inc Company Overview
5.21.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Abdominal Aortic Stent Grafts- Recent Developments
6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.2 May 22, 2018: UT Southwestern surgeons among world’s first to repair aortic arch aneurysm with leading-edge technique
6.3 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC
6.4 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow
6.5 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.6 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical
6.7 May 02, 2018: Endologix Announces First Quarter 2018 Financial Results
6.8 May 02, 2018: Endologix Names John Onopchenko As Chief Executive Officer
6.9 Apr 26, 2018: Vizient Names David F. Ertel as New Chief Financial Officer
6.10 Apr 25, 2018: Endovascular Aneurysm Sealing (EVAS) with Nellix System Associated with Higher Survival than Traditional Endovascular Aneurysm Repair (EVAR) in New Study
6.11 Apr 25, 2018: LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)
6.12 Apr 25, 2018: 2018 Vizient Connections Summit to Focus on Maximizing Supply Chain Operations and Pharmacy Performance
6.13 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management
6.14 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.15 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results
6.16 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results
6.17 Mar 21, 2018: Endospan Receives CE Mark for HORIZON EVAR System Based on Robust Clinical and Pivotal Data to Treat Abdominal Aortic Aneurysm (AAA)
6.18 Mar 19, 2018: Endologix Reports Positive Results from Global ENCORE Analysis with Polymer Endovascular Aneurysm Repair (EVAR) Using Ovation Abdominal Stent Graft Systems
6.19 Mar 05, 2018: Endologix Announces Enrollment of the First Patient in EVAS2 IDE Clinical Study of the Nellix EndoVascular Aneurysm Sealing System
6.20 Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017
6.21 Feb 21, 2018: Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results
6.22 Feb 21, 2018: Endologix Announces Resignation Of John McDermott As Chief Executive Officer
6.23 Feb 12, 2018: Vizient Named as a 2018 World’s Most Ethical Company by the Ethisphere Institute
6.24 Feb 08, 2018: MicroPort Endovascular Hercules Series Products Gain Regulatory Approval in Colombia
6.25 Feb 08, 2018: Joint development agreement for Japan’s first abdominal aortic aneurysm stent graft
6.26 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017
6.27 Feb 05, 2018: Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
6.28 Feb 05, 2018: Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
6.29 Feb 04, 2018: Byron Jobe Leads Vizient as New President and CEO
6.30 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.31 Jan 29, 2018: Endologix Names Greg Morrow As Chief Marketing Officer
6.32 Jan 29, 2018: Endologix Appoints Greg Morrow as Chief Marketing Officer
6.33 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers
6.34 Jan 24, 2018: Medtronic Launches ENCHANT Study to Evaluate ChEVAR Parallel Graft Technique with the Endurant(TM) II/IIs Stent Graft System
6.35 Jan 11, 2018: Vizient to Share GPO Insights on Medical Device Cybersecurity at Jan. 16 Conference
6.36 Jan 08, 2018: Altura Endograft System Granted CFDA Green-Path
6.37 Jan 08, 2018: MicroPort Endovascular Attends CEC 2017
6.38 Jan 08, 2018: Lombard Medical Announces Update on its Loan and Security Agreement
6.39 Jan 03, 2018: First Patient Enrolled in Investigational Study of the GORE EXCLUDER Conformable AAA Endoprosthesis with ACTIVE CONTROL System
6.40 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
6.41 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems
6.42 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
6.43 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
6.44 Nov 07, 2017: Endologix Reports Third Quarter 2017 Financial Results
6.45 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
6.46 Oct 31, 2017: Lombard Medical Reports First Half and Third Quarter 2017 Financial Results
6.47 Oct 26, 2017: LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%)
6.48 Oct 19, 2017: Endologix Appoints John Onopchenko as Chief Operating Officer
6.49 Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria
6.50 Oct 09, 2017: Medtronic Endurant II/IIs Stent Graft System Receives FDA Approval to Treat Short Neck Anatomies When Used with Heli-FX EndoAnchor System
6.51 Oct 06, 2017: Endologix Receives IDE Approval for the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix EndoVascular Aneurysm Sealing System
6.52 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.53 Oct 03, 2017: Vizient Names New President and CEO
6.54 Oct 02, 2017: Celebrating the 20th Anniversary of the GORE EXCLUDER Device
6.55 Sep 26, 2017: Vizient Announces Stephen Downey in Newly Created Role of Group Senior Vice President of Supply Chain Operations
6.56 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California
6.57 Sep 21, 2017: Endologix Announces CE Mark Approval for the Nellix EndoVascular Aneurysm Sealing System with the Refined Indications for Use
6.58 Sep 20, 2017: Lombard Medical Appoints Jonathan Hornsby as Vice President, Sales & Marketing
6.59 Sep 13, 2017: New Five-Year Gender Subset Data from the Medtronic Engage Registry Presented in VIVA Late Breaking Trials
6.60 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY
6.61 Sep 11, 2017: Vizient Deeply Concerned that Proposed CMS Rules Will Harm Hospitals and Negatively Impact Patient Care
6.62 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.63 Aug 17, 2017: Endologix Announces Positive Clinical Results from the LEOPARD Clinical Study
6.64 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261%
6.65 Aug 02, 2017: Endologix Reports Second Quarter 2017 Financial Results
6.66 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%)
6.67 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017
6.68 Jul 21, 2017: Bolton Medical Announces the First Implant in the TREO Global Registry
6.69 Jul 07, 2017: MPSC New COO Glendy Wang on Board

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
Table 2: Abdominal Aortic Stent Grafts - Pipeline Products by Territory
Table 3: Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path
Table 4: Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
Table 5: Abdominal Aortic Stent Grafts - Ongoing Clinical Trials
Table 6: Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
Table 7: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
Table 8: Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Altura Endograft System - Product Status
Table 10: Altura Endograft System - Product Description
Table 11: Altura Medical Inc - Ongoing Clinical Trials Overview
Table 12: Altura Endograft System - Kissing Endografts for Peripheral AAA Exclusion (ELEVATEInternational)
Table 13: Altura Endograft System - Multi-center Observational Post-market Real World Registry
Table 14: Altura Endograft System - The Altura AAA Endograft Safety and Feasibility Study For Exclusion of Abdominal Aortic Aneurysms
Table 15: BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Status
Table 17: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Description
Table 18: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Zenith p-Branch - Product Status
Table 20: Zenith p-Branch - Product Description
Table 21: Cook Medical Inc - Ongoing Clinical Trials Overview
Table 22: Zenith p-Branch - Evaluation of Visceral Function Following Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) Using Branch Stent-Grafts
Table 23: Zenith p-Branch - Study Assessing Safety and Effectiveness of Perivisceral Aortic Aneurysm Treatment with the Zenith Fenestrated AAA Endovascular Graft and the Zenith p-Branch and the Effects on Organ and Extremity Perfusion
Table 24: Zenith p-Branch - Zenith p-Branch Multi-center Study
Table 25: Zenith p-Branch - Zenith p-Branch Pivotal Study
Table 26: Zenith p-Branch - Zenith p-Branch: Single-center Study
Table 27: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 28: INCRAFT AAA Stent Graft - Product Status
Table 29: INCRAFT AAA Stent Graft - Product Description
Table 30: Cordis Corp - Ongoing Clinical Trials Overview
Table 31: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft Stent Graft System in Subjects With Abdominal Aortic Aneurysms: INSPIRATION
Table 32: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Post Approval Study of the INCRAFT Abdominal Aortic Aneurysm (AAA) Stent Graft System in Subjects with Abdominal Aortic Aneurysms
Table 33: INCRAFT AAA Stent Graft - Compassionate Use of the Incraft AAA Stent Graft System
Table 34: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 35: LifeJacket AAA Stent Graft - Product Status
Table 36: LifeJacket AAA Stent Graft - Product Description
Table 37: Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: AFX2 Bifurcated Endograft System - Product Status
Table 39: AFX2 Bifurcated Endograft System - Product Description
Table 40: AFX3 - Product Status
Table 41: AFX3 - Product Description
Table 42: AFX4 - Product Status
Table 43: AFX4 - Product Description
Table 44: Nellix CHEVAS - Product Status
Table 45: Nellix CHEVAS - Product Description
Table 46: Nellix EVAS System - Product Status
Table 47: Nellix EVAS System - Product Description
Table 48: Nellix With Snorkels - Product Status
Table 49: Nellix With Snorkels - Product Description
Table 50: Nellix2 AAA Endovascular System - Product Status
Table 51: Nellix2 AAA Endovascular System - Product Description
Table 52: Ovation Alto Abdominal Stent Graft System - Product Status
Table 53: Ovation Alto Abdominal Stent Graft System - Product Description
Table 54: Paravisceral System - Product Status
Table 55: Paravisceral System - Product Description
Table 56: Ventana 2 - Product Status
Table 57: Ventana 2 - Product Description
Table 58: Xpand BX Covered Stent - Product Status
Table 59: Xpand BX Covered Stent - Product Description
Table 60: Endologix Inc - Ongoing Clinical Trials Overview
Table 61: Nellix EVAS System - Multicenter, Observational, Registry to Assess Outcomes of Patients Treated With the CE Marked Nellix System for Endovascular Abdominal Aortic Aneurysm Repair
Table 62: Nellix EVAS System - Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study: EVAS 2 Confirmatory IDE Study
Table 63: Nellix EVAS System - Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System: A Pivotal and Continued Access Study
Table 64: Nellix EVAS System - Study of a Sealing Type Stent-graft For Abdominal Aortic Aneurysm
Table 65: Xpand BX Covered Stent - Prospective, Multicenter, Single Arm Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms
Table 66: Nellix2 AAA Endovascular System - Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study: EVAS 2 Confirmatory IDE Study
Table 67: Ovation Alto Abdominal Stent Graft System - Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft IDE Study
Table 68: Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Stent-Graft With Adhesive Delivery Platform - Product Status
Table 70: Stent-Graft With Adhesive Delivery Platform - Product Description
Table 71: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 72: In Situ Weldable Hybrid Stent - Product Status
Table 73: In Situ Weldable Hybrid Stent - Product Description
Table 74: Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 75: Abdominal Aortic Aneurysm Stent Graft - Product Status
Table 76: Abdominal Aortic Aneurysm Stent Graft - Product Description
Table 77: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Ankura II AAA Stent Graft - Product Status
Table 79: Ankura II AAA Stent Graft - Product Description
Table 80: Iliac Bifurcation Stent Graft System - Product Status
Table 81: Iliac Bifurcation Stent Graft System - Product Description
Table 82: Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 83: Aorfix Plus Endovascular Stent Graft - Product Status
Table 84: Aorfix Plus Endovascular Stent Graft - Product Description
Table 85: FEVAR - Product Status
Table 86: FEVAR - Product Description
Table 87: Lombard Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 88: Aorfix Flexible Stent Graft System - Product Status
Table 89: Aorfix Flexible Stent Graft System - Product Description
Table 90: Low Profile Stent Graft - Product Status
Table 91: Low Profile Stent Graft - Product Description
Table 92: Lombard Medical Technologies Ltd - Ongoing Clinical Trials Overview
Table 93: Aorfix Flexible Stent Graft System - AAA Registry: Clinical Outcomes of Highly Angulated Anatomy Treated with the Aorfix Stent Graft (ARCHYTAS)

List of Figures
Figure 1: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
Figure 2: Abdominal Aortic Stent Grafts - Pipeline Products by Territory
Figure 3: Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path
Figure 4: Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
Figure 5: Abdominal Aortic Stent Grafts - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Altura Medical Inc
  • BiFlow Medical Ltd
  • Cook Medical Inc
  • Cordis Corp
  • Cytograft Tissue Engineering Inc
  • Endologix Inc
  • Endoluminal Sciences Pty Ltd.
  • Hadassah Medical Center
  • Kawasumi Laboratories Inc
  • Lifetech Scientific (Shenzhen) Co Ltd
  • Lombard Medical Technologies Inc.
  • Lombard Medical Technologies Ltd
  • Medtronic plc
  • MicroPort Scientific Corp
  • St. Jude Medical LLC
  • Terumo Aortic
  • TriVascular Inc
  • University of Colorado Denver
  • University of Limerick
  • Venus MedTech
  • W. L. Gore & Associates Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll